These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
428 results:

  • 1. Stratification to Neoadjuvant Radiotherapy in Rectal cancer by Regimen and Transcriptional Signatures.
    Mahmood U; Blake A; Rathee S; Samuel L; Murray G; Sebag-Montefiore D; Gollins S; West NP; Begum R; Bach SP; Richman SD; Quirke P; Redmond KL; Salto-Tellez M; Koelzer VH; Leedham SJ; Tomlinson I; Dunne PD; Buffa FM; ; Maughan TS; Domingo E
    Cancer Res Commun; 2024 Jul; 4(7):1765-1776. PubMed ID: 39023969
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
    Guan X; Liu R; Wang B; Xiong R; Cui L; Liao Y; Ruan Y; Fang L; Lu X; Yu X; Su D; Ma Y; Dang T; Chen Z; Yao Y; Liu C; Zhang Y
    Clin Transl Med; 2024 Jun; 14(6):e1692. PubMed ID: 38804602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Design, synthesis, insilco study and biological evaluation of new isatin-sulfonamide derivatives by using mono amide linker as possible as histone deacetylase inhibitors.
    Alibeg AAA; Mohammed MH
    Pol Merkur Lekarski; 2024; 52(2):178-188. PubMed ID: 38642353
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
    Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
    ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals cell-cell communication and potential biomarker in sepsis and septic shock patients.
    Li G; Yang Z; Yang C; Xie Y; Gong S; Lv S; Xiao B; Wang J; Weng Q; Wang J; Yu F
    Int Immunopharmacol; 2024 May; 132():111938. PubMed ID: 38593502
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sialylated glycoproteins and sialyltransferases in digestive cancers: Mechanisms, diagnostic biomarkers, and therapeutic targets.
    Zhang SZ; Lobo A; Li PF; Zhang YF
    Crit Rev Oncol Hematol; 2024 May; 197():104330. PubMed ID: 38556071
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis.
    Chen J; Ye J; Zheng X; Chen J
    J Gastrointest Surg; 2024 Mar; 28(3):301-308. PubMed ID: 38445925
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cold atmospheric plasma stabilizes mismatch repair for effective, uniform treatment of diverse colorectal cancer cell types.
    He Y; Lu F; Jiang C; Gong F; Wu Z; Ostrikov K
    Sci Rep; 2024 Feb; 14(1):3599. PubMed ID: 38351129
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. G-quadruplexes promote the motility in MAZ phase-separated condensates to activate CCND1 expression and contribute to hepatocarcinogenesis.
    Wang W; Li D; Xu Q; Cheng J; Yu Z; Li G; Qiao S; Pan J; Wang H; Shi J; Zheng T; Sui G
    Nat Commun; 2024 Feb; 15(1):1045. PubMed ID: 38316778
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
    Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chemotherapy-Enabled colorectal cancer Immunotherapy of Self-Delivery Nano-PROTACs by Inhibiting Tumor Glycolysis and Avoiding Adaptive Immune Resistance.
    Zhao LP; Zheng RR; Rao XN; Huang CY; Zhou HY; Yu XY; Jiang XY; Li SY
    Adv Sci (Weinh); 2024 Apr; 11(15):e2309204. PubMed ID: 38239040
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.
    Dai X; Chen W; Qiao Y; Chen X; Chen Y; Zhang K; Zhang Q; Duan X; Li X; Zhao J; Tian F; Liu K; Dong Z; Lu J
    Cancer Lett; 2024 Feb; 582():216596. PubMed ID: 38101610
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intestinal stent implantation using a water injection device with carbon dioxide and transparent cap: A case report.
    Wang C; Wu J; Zhang X; Lu X
    Medicine (Baltimore); 2023 Dec; 102(48):e36330. PubMed ID: 38050306
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Design of lactoferrin functionalized carboxymethyl dextran coated egg albumin nanoconjugate for targeted delivery of capsaicin: Spectroscopic and cytotoxicity studies.
    Rajput H; Nangare S; Khan Z; Patil A; Bari S; Patil P
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128392. PubMed ID: 38029917
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
    Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. brd4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
    Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W
    Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. IκB kinase-α coordinates brd4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.
    Pecharromán I; Solé L; Álvarez-Villanueva D; Lobo-Jarne T; Alonso-Marañón J; Bertran J; Guillén Y; Montoto Á; Martínez-Iniesta M; García-Hernández V; Giménez G; Salazar R; Santos C; Garrido M; Borràs E; Sabidó E; Bonfill-Teixidor E; Iurlaro R; Seoane J; Villanueva A; Iglesias M; Bigas A; Espinosa L
    EMBO J; 2023 Nov; 42(21):e114719. PubMed ID: 37737566
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers.
    Pouya FD; Salehi R; Rasmi Y; Kheradmand F; Fathi-Azarbayjani A
    Life Sci; 2023 Nov; 332():122083. PubMed ID: 37717622
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors.
    Michielan A; Crispino F; de Pretis N; Sartori C; Decarli NL; de Pretis G; Merola E
    Surg Endosc; 2023 Oct; 37(10):7859-7866. PubMed ID: 37626237
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Relevance of shrinkage versus fragmented response patterns in rectal cancer.
    Kus Ozturk S; Graham Martinez C; Sheahan K; Winter DC; Aherne S; Ryan ÉJ; van de Velde CJ; Marijnen CA; Hospers GA; Roodvoets AG; Doukas M; Mens D; Verhoef C; van der Post RS; Nagtegaal ID
    Histopathology; 2023 Dec; 83(6):870-879. PubMed ID: 37609761
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.